Concepedia

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas

Dara S. Ross, Kelly A. Devereaux, Cao Jin, David YunTe Lin, Yanming Zhang, Antonio Marra, Vicky Makker, Britta Weigelt, Lora H. Ellenson, M. Herman Chui

Modern Pathology · 2021 · 77 citations · 34 references

Open access

Concepts

MedicineOncologyPathologyHistopathologyMolecular OncologyMolecular PathologyEndometrial BiopsyEndometrial CancerTumor HistopathologyUterine PathologyEndometrial Tumor ClassificationHer2 AmplificationHistopathologic BiomarkersHistopathologic InterpretationHuman Epidermal Growth Factor Receptor 2 (Her2) ExpressionMolecular Genetic AssociationMolecular Genetic Testing

References

34

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

Medicine, Oncology, Clinical Informatics +15

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology · 2013 · 13.2K citations · Full text

Medicine, Cancer Biology, Oncology +17

Integrated genomic characterization of endometrial carcinoma

Nature · 2013 · 5.8K citations · Full text

Medicine, Genetics, Oncology +17

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

Donavan T. Cheng, Talia Mitchell, Ahmet Zehir et al. · Journal of Molecular Diagnostics · 2015 · 2.2K citations · Full text

Medicine, Molecular Biology, Oncology +14

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Archives of Pathology & Laboratory Medicine · 2007 · 1.9K citations

Medicine, Oncology, Pathology +11